当前位置:首页 - 行情中心 - 鹭燕医药(002788) - 财务分析 - 现金流量表

鹭燕医药

(002788)

  

流通市值:48.03亿  总市值:48.88亿
流通股本:3.82亿   总股本:3.89亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,816,870,707.9322,904,511,831.116,996,652,201.7811,373,235,408.13
  收到的税费返还462,605.722,6001,464,967.681,389,764.96
  收到其他与经营活动有关的现金109,467,188.1580,549,063.44190,603,420.38107,900,409.15
  经营活动现金流入小计5,926,800,501.822,985,063,494.5417,188,720,589.8411,482,525,582.24
  购买商品、接受劳务支付的现金5,839,584,827.5621,015,638,295.315,886,079,983.0310,587,178,008.98
  支付给职工以及为职工支付的现金168,595,625.15588,068,454.83438,936,783.94300,622,475.73
  支付的各项税费99,994,050.29397,362,442.77301,526,275.51205,399,123.65
  支付其他与经营活动有关的现金68,593,561.31295,594,163.12232,474,668.61178,607,983.8
  经营活动现金流出小计6,176,768,064.3122,296,663,356.0216,859,017,711.0911,271,807,592.16
  经营活动产生的现金流量净额-249,967,562.51688,400,138.52329,702,878.75210,717,990.08
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额22,459.2834,220.96832,458.48751,552.35
  投资活动现金流入小计22,459.2834,220.96832,458.48751,552.35
  购建固定资产、无形资产和其他长期资产支付的现金42,260,792.18233,736,964.18185,657,832.08109,104,123.59
  投资支付的现金010,092,5008,092,5002,092,500
  支付其他与投资活动有关的现金-580,071.56580,071.56-
  投资活动现金流出小计42,260,792.18244,409,535.74194,330,403.64111,196,623.59
  投资活动产生的现金流量净额-42,238,332.98-243,575,314.78-193,497,945.16-110,445,071.24
三、筹资活动产生的现金流量:
  吸收投资收到的现金0618,000618,000618,000
  其中:子公司吸收少数股东投资收到的现金0618,000618,000618,000
  取得借款收到的现金3,040,170,843.19,500,495,716.137,320,034,703.464,644,876,420.77
  收到其他与筹资活动有关的现金0---
  筹资活动现金流入小计3,040,170,843.19,501,113,716.137,320,652,703.464,645,494,420.77
  偿还债务支付的现金2,705,103,287.269,549,761,270.577,249,516,252.134,629,035,984
  分配股利、利润或偿付利息支付的现金43,614,845.03314,126,444.16264,366,607.5989,812,101.34
  其中:子公司支付给少数股东的股利、利润-166,994.96--
  支付其他与筹资活动有关的现金13,341,413.2177,309,465.3249,443,092.0935,532,807.96
  筹资活动现金流出小计2,762,059,545.59,941,197,180.057,563,325,951.814,754,380,893.3
  筹资活动产生的现金流量净额278,111,297.6-440,083,463.92-242,673,248.35-108,886,472.53
四、汇率变动对现金及现金等价物的影响-227,983.98-465,899.86-396,890.77-187,961.55
五、现金及现金等价物净增加额-14,322,581.874,275,459.96-106,865,205.53-8,801,515.24
  加:期初现金及现金等价物余额345,200,364.2340,924,904.24340,924,904.24340,924,904.24
  期末现金及现金等价物余额330,877,782.33345,200,364.2234,059,698.71332,123,389
补充资料:
  净利润-278,981,375.38-153,439,626.26
  资产减值准备-20,211,650.57-8,162,480.48
  固定资产和投资性房地产折旧-69,249,649.37-33,994,619.3
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧---33,994,619.3
  无形资产摊销-5,234,678.7-2,456,876.61
  长期待摊费用摊销-11,129,136.78-5,412,776.11
  处置固定资产、无形资产和其他长期资产的损失--264,930.44--98,166.8
  固定资产报废损失-435,541.72-191,390.26
  财务费用-178,306,026.62-94,698,322.68
  投资损失-14,334,376.29-9,374,070.99
  递延所得税--2,935,608.35--2,915,996.13
  其中:递延所得税资产减少--2,667,504.12--2,758,657.49
    递延所得税负债增加--268,104.23--157,338.64
  存货的减少--176,355,961.4-294,881,254.12
  经营性应收项目的减少--444,365,687.72--297,639,539.91
  经营性应付项目的增加-672,289,020.62--121,928,689.66
  现金的期末余额-345,200,364.2-332,123,389
  减:现金的期初余额-340,924,904.24-340,924,904.24
  现金及现金等价物的净增加额-4,275,459.96--8,801,515.24
公告日期2026-04-212026-04-212025-10-272025-08-26
审计意见(境内)标准无保留意见
TOP↑